Biopharma Sustainability Investor Dialog 2021 (10/13/21)

Stakeholder Dialogs

(Premium, Silver, and Gold subscribers)

• Investor Perspective: Evolving Regulatory and Reporting Landscape
• Emerging EU ‘sustainable finance’ regulation and Biopharma consequences
• Future (best / necessary) practice metrics and KPIs
• Workshop with ESG-oriented asset managers and ESG analysts tbd

Virtual event: https://biopharmasustainability.com/events/biopharma-sustainability-investor-day-2021/?occurrence=2021-10-13